Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)

SHA:605033 Revenue

Shaanxi Meibang Pharmaceutical Group had revenue of 336.34M CNY in the quarter ending March 31, 2026, with 16.21% growth. This brings the company's revenue in the last twelve months to 958.88M, up 11.13% year-over-year. In the year 2025, Shaanxi Meibang Pharmaceutical Group had annual revenue of 911.95M with 2.98% growth.

• Revenue (ttm): 958.88M
• Revenue Growth: +11.13%
• P/S Ratio: 3.08
• Revenue / Employee: 960.80K
• Employees: 998
• Market Cap: 2.96B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	911.95M	26.42M	2.98%
Dec 31, 2024	885.53M	186.50M	26.68%
Dec 31, 2023	699.03M	-207.02M	-22.85%
Dec 31, 2022	906.05M	63.56M	7.54%
Dec 31, 2021	842.49M	273.97M	48.19%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error